194 related articles for article (PubMed ID: 26146823)
1. Immunologic and Virologic Progression in HIV Controllers: The Role of Viral "Blips" and Immune Activation in the ANRS CO21 CODEX Study.
Noel N; Lerolle N; Lécuroux C; Goujard C; Venet A; Saez-Cirion A; Avettand-Fenoël V; Meyer L; Boufassa F; Lambotte O;
PLoS One; 2015; 10(7):e0131922. PubMed ID: 26146823
[TBL] [Abstract][Full Text] [Related]
2. Elevated IP10 levels are associated with immune activation and low CD4⁺ T-cell counts in HIV controller patients.
Noel N; Boufassa F; Lécuroux C; Saez-Cirion A; Bourgeois C; Dunyach-Remy C; Goujard C; Rouzioux C; Meyer L; Pancino G; Venet A; Lambotte O;
AIDS; 2014 Feb; 28(4):467-76. PubMed ID: 24378753
[TBL] [Abstract][Full Text] [Related]
3. CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study.
Kaufmann GR; Perrin L; Pantaleo G; Opravil M; Furrer H; Telenti A; Hirschel B; Ledergerber B; Vernazza P; Bernasconi E; Rickenbach M; Egger M; Battegay M;
Arch Intern Med; 2003 Oct; 163(18):2187-95. PubMed ID: 14557216
[TBL] [Abstract][Full Text] [Related]
4. Nadir CD4 T cell count as predictor and high CD4 T cell intrinsic apoptosis as final mechanism of poor CD4 T cell recovery in virologically suppressed HIV-infected patients: clinical implications.
Negredo E; Massanella M; Puig J; Pérez-Alvarez N; Gallego-Escuredo JM; Villarroya J; Villarroya F; Moltó J; Santos JR; Clotet B; Blanco J
Clin Infect Dis; 2010 May; 50(9):1300-8. PubMed ID: 20367229
[TBL] [Abstract][Full Text] [Related]
5. Immune and virological benefits of 10 years of permanent viral control with antiretroviral therapy.
Guihot A; Tubiana R; Breton G; Marcelin AG; Samri A; Assoumou L; Goncalves E; Bricaire F; Costagliola D; Calvez V; Rouzioux C; Autran B; Katlama C; Carcelain G; ;
AIDS; 2010 Feb; 24(4):614-7. PubMed ID: 19952710
[TBL] [Abstract][Full Text] [Related]
6. HIV-1 control after transient antiretroviral treatment initiated in primary infection: role of patient characteristics and effect of therapy.
Goujard C; Girault I; Rouzioux C; Lécuroux C; Deveau C; Chaix ML; Jacomet C; Talamali A; Delfraissy JF; Venet A; Meyer L; Sinet M;
Antivir Ther; 2012; 17(6):1001-9. PubMed ID: 22865544
[TBL] [Abstract][Full Text] [Related]
7. Assessment of chloroquine as a modulator of immune activation to improve CD4 recovery in immune nonresponding HIV-infected patients receiving antiretroviral therapy.
Routy JP; Angel JB; Patel M; Kanagaratham C; Radzioch D; Kema I; Gilmore N; Ancuta P; Singer J; Jenabian MA
HIV Med; 2015 Jan; 16(1):48-56. PubMed ID: 24889179
[TBL] [Abstract][Full Text] [Related]
8. IL-2 therapy: potential impact of the CD4 cell count at initiation on clinical efficacy--results from the ANRS CO4 cohort.
Fontas E; Kousignian I; Pradier C; Poizot-Martin I; Durier C; Weiss L; Levy Y; Costagliola D; ;
J Antimicrob Chemother; 2010 Oct; 65(10):2215-23. PubMed ID: 20702463
[TBL] [Abstract][Full Text] [Related]
9. Residual viraemia in HIV-1-infected patients with plasma viral load Ostrowski SR; Katzenstein TL; Pedersen BK; Gerstoft J; Ullum H
Scand J Immunol; 2008 Dec; 68(6):652-60. PubMed ID: 19055701
[TBL] [Abstract][Full Text] [Related]
10. Differences in disease progression in a cohort of long-term non-progressors after more than 16 years of HIV-1 infection.
Rodés B; Toro C; Paxinos E; Poveda E; Martinez-Padial M; Benito JM; Jimenez V; Wrin T; Bassani S; Soriano V
AIDS; 2004 May; 18(8):1109-16. PubMed ID: 15166526
[TBL] [Abstract][Full Text] [Related]
11. Short-term and long-term clinical and immunological consequences of stopping antiretroviral therapy in HIV-infected patients with preserved immune function.
Imaz A; Olmo M; Peñaranda M; Gutiérrez F; Romeu J; Larrousse M; Domingo P; Oteo JA; Curto J; Vilallonga C; Masiá M; López-Aldeguer J; Iribarren JA; Podzamczer D;
Antivir Ther; 2013; 18(1):125-30. PubMed ID: 22805174
[TBL] [Abstract][Full Text] [Related]
12. Preserved central memory and activated effector memory CD4+ T-cell subsets in human immunodeficiency virus controllers: an ANRS EP36 study.
Potter SJ; Lacabaratz C; Lambotte O; Perez-Patrigeon S; Vingert B; Sinet M; Colle JH; Urrutia A; Scott-Algara D; Boufassa F; Delfraissy JF; Thèze J; Venet A; Chakrabarti LA
J Virol; 2007 Dec; 81(24):13904-15. PubMed ID: 17928341
[TBL] [Abstract][Full Text] [Related]
13. CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression.
Moore RD; Keruly JC
Clin Infect Dis; 2007 Feb; 44(3):441-6. PubMed ID: 17205456
[TBL] [Abstract][Full Text] [Related]
14. Early immunologic and virologic predictors of clinical HIV-1 disease progression.
Mahnke YD; Song K; Sauer MM; Nason MC; Giret MT; Carvalho KI; Costa PR; Roederer M; Kallás EG
AIDS; 2013 Mar; 27(5):697-706. PubMed ID: 23211771
[TBL] [Abstract][Full Text] [Related]
15. Increased soluble Fas in HIV-infected hemophilia patients with CD4+ and CD8+ cell count increases and viral load and immune complex decreases.
Daniel V; Süsal C; Weimer R; Zimmermann R; Huth-Kühne A; Opelz G
AIDS Res Hum Retroviruses; 2001 Mar; 17(4):329-35. PubMed ID: 11242519
[TBL] [Abstract][Full Text] [Related]
16. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI
Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945
[TBL] [Abstract][Full Text] [Related]
17. Discontinuation of antiretroviral therapy in patients with chronic HIV infection: clinical, virologic, and immunologic consequences.
Mata RC; Viciana P; de Alarcón A; López-Cortés LF; Gómez-Vera J; Trastoy M; Cisneros JM
AIDS Patient Care STDS; 2005 Sep; 19(9):550-62. PubMed ID: 16164382
[TBL] [Abstract][Full Text] [Related]
18. Evidence of immune reconstitution in antiretroviral drug-experienced patients with advanced HIV disease.
Landay AL; Bettendorf D; Chan E; Spritzler J; Schmitz JL; Bucy RP; Gonzalez CJ; Schnizlein-Bick CT; Evans T; Squires KE; Phair JP
AIDS Res Hum Retroviruses; 2002 Jan; 18(2):95-102. PubMed ID: 11839142
[TBL] [Abstract][Full Text] [Related]
19. Close association of CD8+/CD38 bright with HIV-1 replication and complex relationship with CD4+ T-cell count.
Tuaillon E; Al Tabaa Y; Baillat V; Segondy M; Picot MC; Reynes J; Vendrell JP
Cytometry B Clin Cytom; 2009 Jul; 76(4):249-60. PubMed ID: 19072838
[TBL] [Abstract][Full Text] [Related]
20. Low CD4+ T cell nadir is an independent predictor of lower HIV-specific immune responses in chronically HIV-1-infected subjects receiving highly active antiretroviral therapy.
Siddique MA; Hartman KE; Dragileva E; Dondero M; Gebretsadik T; Shintani A; Peiperl L; Valentine F; Kalams SA
J Infect Dis; 2006 Sep; 194(5):661-5. PubMed ID: 16897665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
